Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Part Of The Solution? PBMs See Opportunities In Medicaid Reform

Executive Summary

Amidst a growing chorus of criticism that pharmacy benefit managers are contributing to the problem of high drug costs, PCMA’s Merritt defends the PBM business model and points to its potential for better managing costs in Medicaid.

Advertisement

Related Content

Medicaid Drug Formulary Ideas Floated, But US Manufacturers Are Skeptical
US Medicaid Reform: Legislators Caution CMS Nominee About Coverage Loss
GPhA Rebrands As AAM, Hopes To Change Tenor Of Drug Pricing Debate
Medicaid Reform And Rebates: State “Opt-Out” Proposed At Hearing
Diabetes Rebate Model Challenged On Morality Grounds In Class Action Suit
Drug Pricing: PhRMA Report Aims To Shift Focus To Supply Chain

Topics

Advertisement
UsernamePublicRestriction

Register

PS120051

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel